Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
245
iStent Infinite Trabecular Micro-Bypass System
Glaukos Investigator Site
Cincinnati, Ohio, United States
RECRUITINGMean Diurnal Intraocular Pressure (IOP) 12-Month reduction ≥ 20% from Baseline
Time frame: 12 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.